Downregulation of MYCN through PI3K Inhibition in Mouse Models of Pediatric Neural Cancer
Tene A. Cage(Santa Clara Valley Medical Center), W. Clay Gustafson(Revolution Medicines (United States))
Cited by 28
Related Papers
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
|Cancer Cell|2016|416
EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
|Cancer Cell|2013|264
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
|Cancer Cell|2017|182
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse
|Cancer Cell|2019|148
Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma
|Science Translational Medicine|2012|86